Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
416,598,522
-
Total 13F shares
-
129,960,531
-
Share change
-
+22,940,408
-
Total reported value
-
$483,575,979
-
Put/Call ratio
-
80%
-
Price per share
-
$3.72
-
Number of holders
-
141
-
Value change
-
+$82,159,731
-
Number of buys
-
86
-
Number of sells
-
49
Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q4 2021
As of 31 Dec 2021 CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) had 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 129,960,531 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, GREENOAKS CAPITAL PARTNERS LLC, BAILLIE GIFFORD & CO, TWO SIGMA INVESTMENTS, LP, PNC Financial Services Group, Inc., BlackRock Inc., Ghisallo Capital Management LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA ADVISERS, LP, and CITADEL ADVISORS LLC.
This table shows 142 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.